Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

InSightec ExAblate 2000 Approved For Uterine Fibroids; 3-Year Study Required

Oct 25 2004

Related Content

InSightec ExAblate Panel To Consider International Uterine Fibroid Data

May 03 2004

InSightec Panel Acquiesces Despite Efficacy, Control Group Concerns

Jun 07 2004

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window